FOLH1 and prostate cancer: PSMA PET/MRI-GTVn is more accurate in whole pelvic radiotherapy for high-risk prostate cancer patients because PSMA PET/MRI has higher sensitivity, specificity and diagnostic accuracy than MRI in identifying PLNM.